
|Articles|March 1, 2004
- Volume 0 0
Watching Grandchildren May Hurt the Heart
Advertisement
Grandma's baby-sitting days may be over. Data from the Nurses' Health Study found women who take care of grandchildren for >9 hours a week have a greater risk of developing heart disease. In a study of 54,412 women aged 46 to 71, 321 women were diagnosed with heart disease in 4 years of follow-up. After adjusting the data to take into consideration factors such as weight, age, and education, the probability of heart disease was 1.55 times as high for grandmothers in the 9-hour group, compared with women who did not take care of children at all.
Articles in this issue
over 22 years ago
Interface Speeds Up Prescription Fillingover 22 years ago
New Technologies Top Surveyover 22 years ago
Partnership Addresses Packaging Solutionsover 22 years ago
PDX Software Gets High Marksover 22 years ago
Polar Powder Cold Pak with Magnetic Therapyover 22 years ago
Seal•ONover 22 years ago
SaltAire Sinus Reliefover 22 years ago
Zim's Crack Creme Hand Sanitizerover 22 years ago
CoroWise Plant Sterolsover 22 years ago
CulturelleAdvertisement
Related to this article

Garlic has a long history in traditional medicine, but evidence for its benefits varies by preparation, and patients taking medications that increase bleeding risk should use it with caution.

The costs to patients, their families, their workplaces, and their communities go well beyond dollars and cents.

Across every setting, the pharmacist's role is to build reliable systems around patients so stroke prevention remains safe and sustainable across the care continuum.

Pharmacists can plan career sabbaticals before retirement with smart savings, employer leave options, and intentional steps that balance their finances with their goals.

Like enzymes and coenzymes, monitoring devices and pharmacists may achieve more together than either can alone.

Every responsibility described in this issue depends on a pharmacy workforce with enough time and support to carry it.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Oral PCSK9 Inhibitor Enlicitide Sustains LDL-C Reductions
2
FDA Requires Class-Wide GLP-1 RA Labeling Changes for Potential NAION Risk
3
FDA Approves Pimicotinib for Tenosynovial Giant Cell Tumor
4
Lilly–Hims & Hers GLP-1 Deal Tests Whether Convenience Can Deliver Continuity of Care
5
